<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Overby H</submitter><funding>NIDDK NIH HHS</funding><funding>NIEHS NIH HHS</funding><funding>National Institutes of Health</funding><funding>NIH HHS</funding><pagination>E7039</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7582898</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>21(19)</volume><pubmed_abstract>Brown adipose tissue (BAT) is an important target for obesity treatment and prevention. Soluble epoxide hydrolase (sEH) converts bioactive epoxy fatty acids (EpFAs) into less active diols. sEH inhibitors (sEHI) are beneficial in many chronic diseases by stabilizing EpFAs. However, roles of sEH and sEHI in brown adipogenesis and BAT activity in treating diet-induced obesity (DIO) have not been reported. sEH expression was studied in in vitro models of brown adipogenesis and the fat tissues of DIO mice. The effects of the sEHI, &lt;i>trans&lt;/i>-4-{4-[3-(4-trifluoromethoxy-phenyl)-ureido]-cyclohexyloxy-benzoic acid (&lt;i>t&lt;/i>-TUCB), were studied in vitro and in the obese mice via mini osmotic pump delivery. sEH expression was increased in brown adipogenesis and the BAT of the DIO mice. &lt;i>t&lt;/i>-TU</pubmed_abstract><journal>International journal of molecular sciences</journal><pubmed_title>Soluble Epoxide Hydrolase Inhibition by &lt;i>t&lt;/i>-TUCB Promotes Brown Adipogenesis and Reduces Serum Triglycerides in Diet-Induced Obesity.</pubmed_title><pmcid>PMC7582898</pmcid><funding_grant_id>1R15DK114790-01A1</funding_grant_id><funding_grant_id>R15 DK114790</funding_grant_id><funding_grant_id>P42ES004699</funding_grant_id><funding_grant_id>R15AT008733</funding_grant_id><funding_grant_id>R00DK100736</funding_grant_id><funding_grant_id>R35ES030443</funding_grant_id><funding_grant_id>P42 ES004699</funding_grant_id><pubmed_authors>Graham K</pubmed_authors><pubmed_authors>Bettaieb A</pubmed_authors><pubmed_authors>Hammock BD</pubmed_authors><pubmed_authors>Choi S</pubmed_authors><pubmed_authors>Zeldin DC</pubmed_authors><pubmed_authors>Yang Y</pubmed_authors><pubmed_authors>Zhao L</pubmed_authors><pubmed_authors>Wang S</pubmed_authors><pubmed_authors>Overby H</pubmed_authors><pubmed_authors>Xu X</pubmed_authors><pubmed_authors>Hildreth K</pubmed_authors><pubmed_authors>Morisseau C</pubmed_authors><pubmed_authors>Wan D</pubmed_authors></additional><is_claimable>false</is_claimable><name>Soluble Epoxide Hydrolase Inhibition by &lt;i>t&lt;/i>-TUCB Promotes Brown Adipogenesis and Reduces Serum Triglycerides in Diet-Induced Obesity.</name><description>Brown adipose tissue (BAT) is an important target for obesity treatment and prevention. Soluble epoxide hydrolase (sEH) converts bioactive epoxy fatty acids (EpFAs) into less active diols. sEH inhibitors (sEHI) are beneficial in many chronic diseases by stabilizing EpFAs. However, roles of sEH and sEHI in brown adipogenesis and BAT activity in treating diet-induced obesity (DIO) have not been reported. sEH expression was studied in in vitro models of brown adipogenesis and the fat tissues of DIO mice. The effects of the sEHI, &lt;i>trans&lt;/i>-4-{4-[3-(4-trifluoromethoxy-phenyl)-ureido]-cyclohexyloxy-benzoic acid (&lt;i>t&lt;/i>-TUCB), were studied in vitro and in the obese mice via mini osmotic pump delivery. sEH expression was increased in brown adipogenesis and the BAT of the DIO mice. &lt;i>t&lt;/i>-TU</description><dates><release>2020-01-01T00:00:00Z</release><publication>2020 Sep</publication><modification>2025-04-21T20:36:56.738Z</modification><creation>2020-10-31T09:57:52Z</creation></dates><accession>S-EPMC7582898</accession><cross_references><pubmed>32987880</pubmed><doi>10.3390/ijms21197039</doi></cross_references></HashMap>